Press release |

MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving tuberculosis drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.

Read more

Latest news

What good is a breakthrough medicine if the people who need it can't afford it?